Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Capello

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Hematology & Oncology|September 10, 2013
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsMichela Capello, Paola Cappello, Federica Caterina Linty, et al.
Journal of the National Cancer Institute|September 11, 2019
Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast CancerJohannes F Fahrmann, Jody Vykoukal, Alia Fleury, et al.
Journal of Proteome Research|May 12, 2010
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancerBarbara Tomaino, Paola Cappello, Michela Capello, et al.
Journal of the National Cancer Institute|April 5, 2017
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic CancerMichela Capello, Leonidas E Bantis, Ghislaine Scelo, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
International Journal of Molecular Sciences|August 26, 2022
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune ResponseEhsan Irajizad, Johannes F Fahrmann, James P Long, et al.
Molecular Metabolism|December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loopYihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Nature Communications|January 18, 2019
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicityMichela Capello, Jody V Vykoukal, Hiroyuki Katayama, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Hematology & Oncology|September 10, 2013
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsMichela Capello, Paola Cappello, Federica Caterina Linty, et al.
Journal of the National Cancer Institute|September 11, 2019
Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast CancerJohannes F Fahrmann, Jody Vykoukal, Alia Fleury, et al.
Journal of Proteome Research|May 12, 2010
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancerBarbara Tomaino, Paola Cappello, Michela Capello, et al.
Journal of the National Cancer Institute|April 5, 2017
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic CancerMichela Capello, Leonidas E Bantis, Ghislaine Scelo, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
International Journal of Molecular Sciences|August 26, 2022
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune ResponseEhsan Irajizad, Johannes F Fahrmann, James P Long, et al.
Molecular Metabolism|December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loopYihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Nature Communications|January 18, 2019
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicityMichela Capello, Jody V Vykoukal, Hiroyuki Katayama, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
Pageof 4